LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Over the last 12 months, insiders at LivaNova PLC have bought $0 and sold $3.4M worth of LivaNova PLC stock.
On average, over the past 5 years, insiders at LivaNova PLC have bought $137,141 and sold $2.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $180,856 was made by KOZY WILLIAM A (director) on 2021‑11‑10.
2024-06-03 | Sale | Moore Daniel Jeffrey | director | 56,623 0.1044% | $60.11 | $3.4M | -11.31% | |
2023-03-30 | Sale | McDonald Damien | CEO | 2,220 0.0041% | $42.55 | $94,461 | +17.82% | |
2022-12-15 | Sale | McDonald Damien | CEO | 2,220 0.0042% | $54.56 | $121,123 | -8.09% | |
2022-04-01 | Sale | Moore Daniel Jeffrey | 1,000 0.0018% | $83.42 | $83,416 | -33.78% | ||
2022-03-29 | Sale | McDonald Damien | CEO | 5,568 0.0104% | $81.50 | $453,792 | -31.51% | |
2022-03-02 | Sale | Moore Daniel Jeffrey | 2,000 0.0038% | $80.00 | $160,000 | -26.43% | ||
2022-02-25 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0037% | $80.00 | $160,000 | -27.47% | |
2022-01-03 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0037% | $85.93 | $171,868 | -27.21% | |
2021-12-13 | Sale | McDonald Damien | CEO | 5,568 0.0104% | $81.50 | $453,792 | -21.03% | |
2021-12-01 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0038% | $81.73 | $163,468 | -19.25% | |
2021-11-11 | Sale | Novak Alfred J | director | 4,674 0.0088% | $89.17 | $416,794 | -23.90% | |
2021-11-10 | Sale | Novak Alfred J | director | 1,288 0.0024% | $90.77 | $116,906 | -25.85% | |
2021-11-10 | KOZY WILLIAM A | director | 2,000 0.0037% | $90.43 | $180,856 | -25.85% | ||
2021-11-03 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0036% | $85.25 | $170,500 | -21.97% | |
2021-10-01 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0037% | $80.00 | $160,000 | -7.45% | |
2021-09-01 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0038% | $82.40 | $164,803 | -6.51% | |
2021-08-02 | Sale | Moore Daniel Jeffrey | director | 2,000 0.0038% | $86.39 | $172,777 | -9.11% | |
2021-06-29 | Sale | Moore Daniel Jeffrey | director | 2,000 0.004% | $84.20 | $168,400 | -5.40% | |
2021-05-18 | Sale | Dolci Marco | SVP Global Operations, R&D | 15,537 0.0323% | $82.89 | $1.29M | +0.21% | |
2020-06-16 | Novak Alfred J | director | 2,000 0.004% | $46.71 | $93,426 | +31.20% |
Moore Daniel Jeffrey | 27534 0.0457% | $54.47 | 0 | 49 | ||
EQUINOX TWO S.C.A. | 10 percent owner | 4863369 9.0278% | $54.47 | 0 | 12 | |
McDonald Damien | CEO | 111847 0.2076% | $54.47 | 0 | 15 | |
WISE DAVID S | Chief Administrative Officer | 27929 0.0518% | $54.47 | 0 | 11 | |
Huston Thad Allen | Chief Financial Officer | 16169 0.03% | $54.47 | 0 | 2 | |
Novak Alfred J | director | 11368 0.0211% | $54.47 | 1 | 9 | +31.2% |
Gutedel Jacques | President Intercontinental | 10948 0.0203% | $54.47 | 0 | 1 | |
KOZY WILLIAM A | director | 6320 0.0117% | $54.47 | 2 | 0 | <0.0001% |
O'Kane Sharon | director | 1000 0.0019% | $54.47 | 1 | 0 | +38.71% |
Manko Douglas John | Chief Accounting Officer | 988 0.0018% | $54.47 | 0 | 1 | |
Simpson Alistair | General Manager, CS | 382 0.0007% | $54.47 | 0 | 1 | |
Dolci Marco | SVP Global Operations, R&D | 0 0% | $54.47 | 0 | 1 | |
MORRISON HUGH M | director | 0 0% | $54.47 | 0 | 5 | |
Bianchi Francesco | director | 0 0% | $54.47 | 0 | 1 |
BlackRock | $411.01M | 13.57 | 7.35M | -0.92% | -$3.83M | 0.01 | |
PRIMECAP Management Co | $332.12M | 10.96 | 5.94M | +2.52% | +$8.16M | 0.25 | |
Barrow Hanley Global Investors | $132.02M | 4.36 | 2.36M | -0.51% | -$675,139.86 | 0.45 | |
Millennium Management LLC | $127.49M | 4.21 | 2.28M | +4.13% | +$5.06M | 0.09 | |
State Street | $111.82M | 3.69 | 2M | +0.56% | +$623,898.82 | 0.01 | |
The Vanguard Group | $102.54M | 3.39 | 1.83M | +3.53% | +$3.5M | <0.01 | |
Ameriprise Financial | $82.89M | 2.74 | 1.48M | +16.77% | +$11.91M | 0.02 | |
Citadel Advisors LLC | $81.2M | 2.68 | 1.45M | +26.1% | +$16.8M | 0.05 | |
Dimensional Fund Advisors | $77.09M | 2.55 | 1.38M | +10.96% | +$7.61M | 0.02 | |
Barclays | $75.92M | 2.51 | 1.36M | +40.09% | +$21.73M | 0.03 | |
Geode Capital Management | $71.21M | 2.35 | 1.27M | +3.9% | +$2.67M | 0.01 | |
Bank of America | $60.95M | 2.01 | 1.09M | +2.85% | +$1.69M | 0.01 | |
Redmile Group | $58.05M | 1.92 | 1.04M | -8.73% | -$5.55M | 2.15 | |
Loomis, Sayles & Company | $50.99M | 1.68 | 911,511 | -2.05% | -$1.07M | 0.07 | |
Victory Capital Management Inc | $45.84M | 1.51 | 819,509 | -1.28% | -$592,460.55 | 0.05 | |
Vernier Capital Partners LP | $44.75M | 1.48 | 800,000 | -5.88% | -$2.8M | 5.29 | |
Allspring Global Investments | $44.12M | 1.46 | 788,761 | -4.92% | -$2.28M | 0.07 | |
Nuveen | $43.51M | 1.44 | 777,754 | +40.2% | +$12.47M | 0.01 | |
Magnetar Capital | $42.14M | 1.39 | 753,338 | +24.49% | +$8.29M | 1.18 | |
Marshall Wace | $39.82M | 1.32 | 711,832 | -5.98% | -$2.53M | 0.05 | |
Emerald Advisers, Inc. | $39.45M | 1.3 | 705,297 | +44.4% | +$12.13M | 1.6 | |
Morgan Stanley | $35.89M | 1.19 | 641,659 | +5.22% | +$1.78M | <0.01 | |
Northern Trust | $34.33M | 1.13 | 613,780 | -8.25% | -$3.09M | 0.01 | |
Cardinal Capital Management Llc Ct | $31.15M | 1.03 | 556,841 | -13.22% | -$4.75M | 1.59 | |
EMERALD MUTUAL FUND ADVISERS TRUST | $30.43M | 1.01 | 543,979 | +39.41% | +$8.6M | 1.6 | |
AllianceBernstein | $29.41M | 0.97 | 525,802 | -65.94% | -$56.94M | 0.01 | |
Point72 Asset Management | $29.23M | 0.97 | 522,479 | -49.84% | -$29.04M | 0.06 | |
Charles Schwab | $29.02M | 0.96 | 518,842 | +2.36% | +$669,601.79 | 0.01 | |
Clearline Capital LP | $27.93M | 0.92 | 499,339 | -9.97% | -$3.09M | 2.76 | |
BNY Mellon | $27.18M | 0.9 | 485,830 | -5.34% | -$1.53M | 0.01 | |
Goldman Sachs | $26.94M | 0.89 | 481,524 | -12.88% | -$3.98M | 0.01 | |
JPMorgan Chase | $26.55M | 0.88 | 474,561 | +189.39% | +$17.37M | <0.01 | |
Paradice Investment Management | $23.55M | 0.78 | 420,927 | -22.86% | -$6.98M | 4.08 | |
Hawk Ridge Capital Management | $22.94M | 0.76 | 410,157 | -37.13% | -$13.55M | 1.03 | |
State of Wisconsin Investment Board | $19.2M | 0.63 | 343,285 | -39.08% | -$12.32M | 0.05 | |
Driehaus Capital Management LLC | $18.48M | 0.61 | 330,293 | New | +$18.48M | 0.19 | |
Ubs Asset Management Americas Inc | $18.33M | 0.61 | 327,639 | -57.13% | -$24.43M | 0.01 | |
Kennedy Capital Management Inc | $17.16M | 0.57 | 306,705 | -1.6% | -$278,357.45 | 0.36 | |
Perceptive Advisors | $16.73M | 0.55 | 299,000 | New | +$16.73M | 0.01 | |
D. E. Shaw & Co. | $15.1M | 0.5 | 269,955 | +19.48% | +$2.46M | 0.02 | |
Schonfeld Group | $15.1M | 0.5 | 269,848 | New | +$15.1M | 0.11 | |
Mesirow Institutional Investment Management Inc | $13.82M | 0.46 | 246,975 | New | +$13.82M | 1.23 | |
Amundi | $12.26M | 0.43 | 232,412 | +41.49% | +$3.6M | 0.01 | |
Perpetual Limited | $12.28M | 0.41 | 219,528 | +3.02% | +$360,029.83 | 0.12 | |
Two Sigma | $12.22M | 0.4 | 218,361 | +233.49% | +$8.55M | 0.02 | |
Citigroup | $11.93M | 0.39 | 213,349 | +2,129.82% | +$11.4M | 0.01 | |
Russell Investments Group Ltd | $11.7M | 0.39 | 209,400 | -7.12% | -$896,103.60 | 0.02 | |
Boothbay Fund Management LLC | $11.55M | 0.38 | 206,543 | +82.57% | +$5.23M | 0.39 | |
Oberweis Asset Management Inc | $11.33M | 0.37 | 202,500 | +172.91% | +$7.18M | 0.82 | |
RhumbLine Advisers | $10.21M | 0.34 | 182,473 | +1.51% | +$151,429.15 | 0.01 |